Forensic toxicology laboratories are often required to implicate or exclude poisoning as a factor in a death or unexplained illness. An analytical tool which enables toxicologists to screen a wide variety of common poisons would be extremely useful. In this paper, we describe the use of a bacterial biosensor for detecting the presence of commonly encountered potentially toxic chemicals in urine. The biosensor responds to any chemical that causes metabolic stress to the bacterial cell and the response is in direct proportion to the concentration of the stressor. This allows a measure of the concentration of a toxicant in urine, without knowing exactly what the toxic compound(s) may be. This affords a distinct advantage over conventional analytical techniques, which require an extensive screening program before it is even known that a toxic compound is present. This preliminary investigation has shown that this biosensor can indicate the presence, in urine, of herbicides such as glyphosate, 2,4-dichlorophenoxyacetic acid, and 2,4,5-trichlorophenoxyacetic acid; the biocide pentachlorophenol; or inorganic poisons such as arsenic, mercury, and cyanide. The biosensor was also shown to be sensitive to a concentration range of these toxicants likely to be found in samples submitted for toxicological analysis.
Introduction
Forensic toxicology laboratories are frequently asked to implicate or exclude chemical poisoning as a factor in a death or unexplained illness. A comprehensive toxicological screen includes a large number of tests for an array of potential poisons with greatly differing chemical structures. Despite the increasing range and sophistication of modern instrumental techniques, such screens can be very costly, and, consequently, only limited screening, dictated by individual case circumstances, is performed.
Biosensors are defined as analytical devices incorporating a biological sensor, such as a microorganism or an enzyme, that can provide an information linked response to a specific challenge, that is, the presence of a toxic chemical, via a suitable transducer (e.g., electrochemical, optical) (1) . Biosensors have applications in numerous fields, including medicine testing 9 Author to whom correspondence should be addressed.
(2--4), environmental testing, (5--7) , and food quality testing (8, 9) . Bacterial biosensors are organisms whose stress responses can be used as tools to detect a specific stress such as that posed by the presence of a toxic compound. Bacteria are stable, easily maintained at a low cost, and a large number of cells can be exposed to a toxin in one study, making them an ideal organism for rapid screening of solutions (7) . Bacterial biosensors have several advantages over classical laboratory techniques. They are generally simple and cheap to culture and have the ability to operate in complex matrices (1) . Furthermore, the selection of a specific microorganism can be made to ensure relevance; for example, in soil environments, the choice of a relevant biosensor would ensure representation of the correct ecological niche and accurately reflect the response of the wild type soil organism to stress. Genetic modification can greatly enhance the detection of the microbial biosensor response, primarily through the use of reporter genes (e.g., bacterial bioluminescence).
In this preliminary study, we used a bacterial biosensor genetically modified with genes for bioluminescence. Luminescent bacteria are the most abundant and widespread of the luminescent organisms found in nature. The genes responsible for light emission in a few of these organisms have been well characterized. The genetic system required for luminescence in the bacterium Photobacterium (Vibiro) fischeri is the lux operon. The lux operon contains two genes for the luciferase enzyme (A and B). This enzyme is composed of two different polypeptide chains. The operon also contains several other genes (C, D, and E) that are thought to code for enzymes (fatty acid reductase complex) that produce the substrates for the light-emitting reaction. These substrates are called luciferins and are long chain fatty aldehydes (10) . Light emission results from the luciferase catalyzing a reaction between oxygen, a reduced flavin mononucleotide, and a long-chain fatty aldehyde. Most micro-organisms lack the genetic blueprint for luciferase and the fatty acid reductase, but they can supply the flavin mononucleotide; therefore, for dark bacteria to become bioluminescent, all that is required is the genetic transfer of the lux operon. The bacterial strain used in our assay was constructed by transformation with plasmid pUCD607, which carries the lux genes (11) . In brief, the lux genes are joined to plasmid DNA (small circular DNA molecules that exist apart from the chromosomes) to form a hybrid, or recombinant molecule that is able to replicate in bacteria. In order to prepare a recombinant molecule, the plasmid and gene of interest are cut at precise positions by specific deoxyribonucleases (restriction endonucleases) and then the molecules are spliced together to form a new plasmid (pUCD607). The lux genes are placed behind a constitutive promoter in the plasmid, which means they are expressed continuously. After the hybrid plasmid molecule has been prepared, it is introduced into bacterial cells by transformation. The hybrid plasmid replicates in the dividing bacterial cells to produce an enormous number of copies of the original gene. The construction of the plasmid is such that under normal conditions, the bacteria will bioluminesce, that is, give out visible light. Bioluminescence is particularly useful because it is extremely sensitive and is sufficiently rapid to allow real-time monitoring (10, 12) . The light output is directly proportional to the metabolic activity (i.e., health) of the biosensor. Any chemical that causes metabolic stress to the bacterial cell will result in a decline in luminescence that is in direct proportion to the concentration of toxic compound present. This gives a measure of the overall toxicity to the organism of a sample and requires no pre-knowledge about the specific compound present in the sample (as is necessary when employing standard chemical analysis), thus biosensors have the potential to provide a rapid screening test applicable to forensic toxicology. The/u.x-marked bacterial biosensors have successfully been used to detect a variety of pollutants in the terrestrial environment [e.g., heavy metals (13); pesticides (14) ; BETX (15); organotins (16) ] and are used commercially by an environmental diagnostics company (Rernedios TM) to characterize contaminated land in the United Kingdom (www.remedios.uk.com).
In this preliminary study, Bscherichia coli HB101 pUCD607 was used to evaluate the sensitivity of this biosensor to a variety of potentially toxic chemicals (PTCs) commonly encountered in forensic toxicology. E. coli was chosen because it is an ubiquitous organism and robust enough to operate in complex samples such as urine.
Experimental

Urine screen
Initially, 22 urine samples were collected from volunteers to determine the range in pH, color, and biosensor response. The volunteers were random "healthy" volunteers on staff at ESR.
No effort was made to exclude volunteers with concurrent medications. All the urines were collected between 9 a.m. and 12 p.m. on the same day. Urine color was compared by measuring absorbance. An arbitrary wavelength of 500 nm at the yellow/green end of the visible spectrum was chosen, and a Lambda Bio UVNIS Spectrometer (PerkinEImer) was used for measurements.
Preparation of PTC standards
The PTCs selected for initial testing represented compounds that are either encountered relatively frequently by toxicologists and/or can only be detected by individual tailored and time consuming tests. The PTCs were N-(phosphonomethyl)glycine (glyphosate) and the commercial formulation of this herbicide "Roundup | 2,4-dichlorophenoxyacetic acid (2,4-D) (sodium salt), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) (sodium salt), methyl viologen dichloride (paraquat) and the commercial formulation "Gramoxone | gamma hydroxybutyrate (GHB), ethylene glycol, sodium cyanide, sodium arsenate, sodium arsenite, mercuric chloride, sodium fluoroacetate (1080), phenol, and pentachlorophenol (PCP) ( Table I) . Stock solutions were made up as follows: 1000 mg of each of the chemicals were individually weighed out using a five-point balance, transferred to acidwashed 1000-mL glass volumetric flasks, and made up to the mark with fresh urine. For 2,4-D and 2,4,5-T, 1000 mg was added to approximately 800 mL of urine and then concentrated sodium hydroxide was added drop by drop until the compounds dissolved, then made up to 1000 mL with urine. Test solutions were made by diluting the stock solutions to the required concentration with urine. The urine used in all the PTC screens, was provided by one subject.
Methods
The biosensor consisted of lyophilized cells ofEscherichia coli HB101 genetically modified with the lux CDABE genes, originally isolated from Vibrio fischeri, using the multicopy plasmid pUCD607 (7).
The biosensor was resuscitated from freeze-dried vials for i h in 10 mL 0.1M KC1 and used directly (7) . A suspension of cells (100 pL) was added to 900 pL of test solution and mixed by pipetting for 5 s at 15-s intervals between each sample. Luminescence was measured in a LumiSkan TL (Labsystems) at 550 nm after a 15-min exposure. All assays were carried out in triplicate using independent vials. Data were expressed as a percentage of the luminescence measured in control urine samples.
Quality assurance of biosensors
The biosensor was kindly supplied by The University of Aberdeen. To assure the quality of the response, the biosensor was exposed to test solutions containing serial dilutions of TCP TM liquid antiseptic (Pfizer Ltd., Sandwich, U.K.), an aqueous glycerol solution of halogenated phenols (0.68% w/v) and phenol (0.175% w/v). The effect of urine on the biosensor response was determined by comparing the TCP TM ECs0 in both urine and water.
Data interpretation
The bioluminescence was plotted as a percentage of the response of the biosensor to the unadulterated urine (control) against PTC concentration. Negative exponential curves were fitted to the data points by non-linear regression techniques for most of the PTCs. The decline in bioluminescence 
Results
Urine screen
Urine pH and color varied considerably among the 22 samples analyzed (data not shown). The pH ranged from 5.5 to 7.3 with an average of 5.6. The color of urine was also highly variable, ranging from very dark (absorbance of 0.82) to very pale (absorbance of 0.02). Bioluminesence of the bacterial biosensor ranged from 0.03 to 1.08 relative light units (RLUs). A multiple regression analysis was carried out to determine if there was a relationship between color, pIi, and luminescence. A log trans- form was applied to the luminescence variable prior to the analysis. Results indicated that there was a linear relationship between these three variables (adjusted R 2 for the model was 0.64, p < 0.0001) and that pH and color could be used to predict luminescence. It should be noted that the analysis was carried out on a limited number of samples provided by volunteers. To improve the prediction of the model a more extensive screen should be undertaken. Results also indicated that at pH values below 6, luminesence is low. The urine used in all the PTC screens was provided by one subject and had a very consistent pH (6.9 + 0.14), well within the pH range of urines from healthy individuals [typical range between 4.8 and 7.5 (17)]. This individual's urine was selected for use in the PTC screens because the subject was available on call to provide urine and because the urine had a relatively high luminescence thus providing a greater range for test samples (0.8 RLUs).
Response of biosensor to PTCs
The plotted graphs of bioluminescence as a percentage of the unadulterated urine (control) against PTC concentration, provide a rapid method of assessing the effect of the toxin on the metabolism of the organism. Results from toxicity testing of aqueous standards of PTCs showed the use of lux-marked bacteria provides appropriate sensitivity for testing of a broad spectrum of PTCs. The ECs0 values for the PTCs are shown in Table I . Exposure of the biosensor to phenol, resulted in a stimulation in bioluminescence with increasing concentration of the toxic compound ( Figure 2 ).
For paraquat (pure chemical formulation and commercial formulation), GHB, 1080, and ethylene glycol, an ECs0 was not reached, even at concentrations up to 500 mg/L.
Discussion
A bioluminescent biosensor was shown to be a useful tool for estimating the toxicity of urine samples. The biosensor was able to indicate the presence of a toxic substance in aqueous standards at concentrations likely to be found in toxicological samples. In some instances (e.g., phenol), presence of a PTC may cause an increase in bioluminescence. This is still a biosensor "response" to the presence of a compound and it may be possible to calculate an effective concentration that causes a 50% increase in luminescence (EC150). It is probable that the biosensor is using phenol as a carbon source, hence increasing the organism's metabolism and resulting in an increase in bioluminescence. However, caution must be taken when interpreting these results as urine may contain utilisable substrates which may increase the bioluminescence response of the organism. Indeed, the effect of common over-the-counter compounds such as ibuprofen, or compounds such as caffeine and oral contraceptives were not measured in this preliminary work. Thus, the rapid screening for PTCs in urine must be interpreted as a balance between the effect of toxins and the response to substrates. For some PTCs, paraquat (pure chemical formulation and commercial formulation), GHB, 1080, and ethylene glycol, the biosensor was not sensitive to the significant toxicological concentrations in urine (Table I) ; therefore, this biosensor is unlikely to be usefuI in detecting these chemicals in forensic toxicological samples.
To date, the E. coli biosensor has primarily been used in environmental testing (6, 14, 25) , and validation of the biosensor response to PTCs has been carried out in water based media (e.g., soil solution). Thus, it was necessary to determine if the biosensor response could also be validated in urine. The QA test solution (TCP) results showed that urine does not significantly effect the biosensor response or the ECs0 for this compound. Thus, the protocol developed for environmental testing can also be used for the testing of urine samples.
The urine screen suggested that luminescence was significantly reduced in samples with a pH < 6. Luminescence response from the biosensor has been shown to be stable across the pH range 4.5-7.0 (7). Consequently, one of the limitations of the technique could be the presence of compounds in urine [e.g., ammonium (26) ] that affect both its color and pH and reduce the light output of the biosensor in a manner similar to a toxicity response. Results for the bacterial biosensor response are normally compared to those of a non-contaminated reference sample of similar physical make-up; thus, variations in luminescence caused by pH and color are removed. However, obtaining a "control" forensic sample will not usually be possible. It may, however, be possible to use a "control" urine that has been matched in both colour and pH to the toxicological sample, as statistical analysis of the urine screen results suggest that both of these variables can be used to predict luminescence. An alternative control may be obtained after processing of the toxicological sample to remove any compounds present (e.g., metals removed by passing the sample through activated carbon) (27) . A second and more promising method used in environmental testing is the "flash assay". In the "flash assay", the control reading is replaced with the peak luminescence observed immediately after addition of the bacteria into the actual sample. Luminescence is recorded 20 times/s for the first 30 s after dispensing and this becomes your reference or control value. The luminescence of the sample is then measured in the usual manner after a 15-min exposure time. The color and pH effects are therefore taken into account throughout the whole measurement period. The ratio of these two luminescence values is used as a measure of the toxicity of the sample (28) . Constraints on the use of the "flash assay" would be that light-output of the biosensor is reduced to background by pH and/or urine color; hence, the biosensor would be unable to detect the presence of toxins over and above this effect. Buffering of samples may be an option for future optimization of the assay. However, adjustment of the pH of a sample may not be a simple matter as it may alter the form and availability of toxins to the biosensor. In addition, results from the urine screen suggested that both pH and urine color affected light-output of the biosensor. More work is needed to optimize the assay and to determine the best "control". Another limitation of the tool is that forensic toxicology urine samples are normally preserved by the addition of sodium fluoride (1-2% w/v); this is added primarily to inhibit microbial growth and changes in concentrations of alcohol and other chemicals in the sample (29, 30) . We have shown that the bacterial biosensor is inhibited by the presence of sodium fluoride, and therefore we were unable to validate the biosensor using actual forensic toxicological samples. For routine use of the biosensor in screening toxicological samples a urine sample should be collected without the sodium fluoride preservative.
Future application of such biosensor technology in forensic toxicology analysis may lie with the design of more specific biosensors. The reporter gene (lux) can be fused to genes involved with a particular response. For example, Rod et al. (31) used a bacterial biosensor with a luciferase gene fused to a gene encoding resistance to mercury. The highly sensitive mercury biosensor was used to detect urinary mercury from amalgam fillings. For many herbicides, bacterial resistance genes have been identified and it may be possible to design a whole suite of specific bacterial biosensors.
Conclusions
Bacterial biosensors are not as specific, sensitive or accurate as chemical testing but are relatively cheap, easy to use, reproducible, and rapid (incubation time is 15 min for most chemicals). The applicability of this system is the rapid broad spec-trum screening of forensic toxicological samples for the presence or absence of PTCs, as a pointer for further confirmatory chemical testing.
